Diffuse large B-cell lymphoma | Department of Medicine Blog

Diffuse Large B-cell Lymphoma Associated With Exposure to Agent Orange

Tom C, Klickstein J, Chen M, Lewis M, Lazarus ME. Diffuse Large B-cell Lymphoma Associated With Exposure to Agent Orange. Cureus. 2026 Jun 5;18(6):e110317. doi:[...]

By afschroeder • July 6, 2026

Primary Cardiac Diffuse Large B-Cell Lymphoma Managed With Rituximab, Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (R-EPOCH): A Case Report and Literature Review

Tai JW, Roufeh EN, Reed JP. Primary Cardiac Diffuse Large B-Cell Lymphoma Managed With Rituximab, Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (R-EPOCH): A Case Report[...]

By afschroeder • June 17, 2025

Phase 1b/2 study of ibrutinib and lenalidomide with dose-adjusted EPOCH-R in patients with relapsed/refractory diffuse large B-cell lymphoma

Wilson WH, Phillips T, Popplewell L, de Vos S, Chhabra S, Kimball AS, Beaupre D, Huang DW, Wright G, Kwei K, Ping J, Neuenburg JK,[...]

By sjmartinez • February 10, 2023

R-CHOP Vs DA-EPOCH-R for Double-Expressor Lymphoma: A University of California Hematologic Malignancies Consortium Retrospective Analysis

Othman T, Penaloza J, Zhang S, Daniel CE, Gaut D, Oliai C, Brem EA, Baweja A, Ly J, Reid J, Pinter-Brown L, Lee M, Abdulhaq[...]

By rosaguerrero • July 21, 2022